切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2018, Vol. 07 ›› Issue (01) : 30 -34. doi: 10.3877/cma.j.issn.2095-3259.2018.01.007

所属专题: 文献

专家论坛

介入性产前诊断并发症的发生及处理
黄林环1, 王子莲1,()   
  1. 1. 510080 广州,中山大学附属第一医院妇产科
  • 收稿日期:2017-11-04 出版日期:2018-02-18
  • 通信作者: 王子莲

Treatment of complications by invasive procedures for prenatal diagnosis

Linhuan Huang1, Zilian Wang1()   

  • Received:2017-11-04 Published:2018-02-18
  • Corresponding author: Zilian Wang
引用本文:

黄林环, 王子莲. 介入性产前诊断并发症的发生及处理[J]. 中华产科急救电子杂志, 2018, 07(01): 30-34.

Linhuan Huang, Zilian Wang. Treatment of complications by invasive procedures for prenatal diagnosis[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2018, 07(01): 30-34.

介入性产前诊断是早、中孕期通过有创的穿刺技术包括绒毛活检、羊膜腔穿刺、脐带穿刺和胎儿组织活检等获取胎儿细胞对其进行染色体核型分析或基因检测,达到在宫内诊断胎儿先天性疾病的目的,其相关并发症包括胎儿丢失、出血、羊水渗漏、胎膜早破、感染、胎儿心动过缓和胎儿损伤以及与操作相关的母亲并发症等,其并发症的早期识别及处理对减少母胎风险具有重要意义。

The invasive prenatal diagnosis is obtained cells from the fetus through chorionic villus sampling, amniocentesis, cordocentesis and fetal biopsy to determine chromosomal or genetic disorders in the fetus during first trimester and second trimester, which is in order to diagnose fetal congenital disease before birth. The related complications include fetal loss, bleeding, amniotic fluid leakage, premature rupture of membranes, infection, fetal bradycardia, fetal injury and maternal complications related to the operation. Early identification and treatment of complications help to reduce the maternal-fetal risk.

[1]
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy [J]. Obstet Gynecol, 2007, 110(6): 1459-1467.
[2]
Royal College of Obstetricians and Gynaecologists (RCOG). Amniocentesis and Chorionic Villus Sampling[R]. Green Top Guideline No.8. London: RCOG Press, 2010.
[3]
Papp C, Beke A, Mezei G, et al. Chorionic villus sampling: a 15-year experience [J]. Fetal Diagn Ther, 2002, 17(4): 218-227.
[4]
Tabor A, Vestergaard CH, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study [J]. Ultrasound Obstet Gynecol, 2009, 34(1): 19-24.
[5]
Wulff CB, Gerds TA, Rode L, et al. The risk of fetal loss associated with invasive testing following combined first trimester risk screening for Down syndrome-a national cohort of 147 987 singleton pregnancies [J]. Ultrasound Obstet Gynecol, 2016, 47(1): 38-44.
[6]
Odibo AO, Dicke JM, Gray DL, et al. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling [J]. Obstet Gynecol, 2008, 112(4): 813-819.
[7]
Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis [J]. Ultrasound Obstet Gynecol, 2015, 45(1): 16-26.
[8]
Milunsky A. Genetic disorders and the fetus: diagnosis, prevention, and Treatment [M]. 5th ed. Baltimore (MD): Johns Hopkins University Press, 2004: 1-65.
[9]
Brambati B, Tului L, Cislaghi C, et al. First 10, 000 chorionic villus samplings performed on singleton pregnancies by a single operator [J]. Prenat Diagn, 1998, 18(3): 255-266.
[10]
Akolekar R, Bower S, Flack N, et al. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling [J]. Prenat Diagn, 2011, 31(1): 38-45.
[11]
Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women [J]. Lancet, 1986, 1(8493): 1287-1293.
[12]
Uludag S, Aydin Y, Ibrahimova F, et al. Comparison of complications in second trimester amniocentesis performed with 20G, 21G and 22G needles [J]. J Perinat Med, 2010, 38(6): 597-600.
[13]
Seeds JW. Diagnostic mid trimester amniocentesis: how safe? [J]. Am J Obstet Gynecol, 2004, 191(2): 607-615.
[14]
Kahler C, Gembruch U, Heling KS, et al. DEGUM guidelines for amniocentesis and chorionic villus sampling [J]. Ultraschall Med, 2013, 34(5): 435-440.
[15]
Towner D, Currier RJ, Lorey FW, et al. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening [J]. Am J Obstet Gynecol, 2007, 196(6): 608.e1-608.e5.
[16]
Harper LM, Cahill AG, Smith K, et al. Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling [J]. Obstet Gynecol, 2012, 119(4): 745-751.
[17]
Tongsong T, Wanapirak C, Kunavikatikul C, et al. Fetal loss rate associated with cordocentesis at midgestation [J]. Am J Obstet Gynecol, 2001, 184(4): 719-723.
[18]
Maxwell DJ, Johnson P, Hurley P, et al. Fetal blood sampling and pregnancy loss in relation to indication [J]. Br J Obstet Gynaecol, 1991, 98(9): 892-897.
[19]
Antsaklis A, Daskalakis G, Papantoniou N, et al. Fetal blood sampling--indication-related losses [J]. Prenat Diagn, 1998, 18(9): 934-940.
[20]
Ghidini A, Sepulveda W, Lockwood CJ, et al. Complications of fetal blood sampling [J]. Am J Obstet Gynecol, 1993, 168(5): 1339-1344.
[21]
Liao C, Wei J, Li Q, et al. Efficacy and safety of cordocentesis for prenatal diagnosis [J]. Int Gynecol Obstet, 2006, 93(1): 13-17.
[22]
Jahoda MG, Pijpers L, Reuss A, et al. Evaluation of transcervical chorionic villus sampling with a completed follow-up of 1550 consecutive pregnancies [J]. Prenat Diagn, 1989, 9(9): 621-628.
[23]
Athanasiadis AP, Pantazis K, Goulis DG, et al. Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications [J]. Prenat Diagn, 2009, 29(8): 761-765.
[24]
Hogge WA, Thiagarajah S, Brenbridge AN, et al. Fetal evaluation by percutaneous blood sampling [J]. Am J Obstet Gynecol, 1988, 158(1): 132-136.
[25]
Rujiwetpongstorn J, Tongsong T, Wanapirak C. Feto-maternal hemorrhage after cordocentesis at Maharaj Nakorn Chiang Mai Hospital [J]. J Med Assoc Thai, 2005, 88(2): 145-149.
[26]
Weiner CP, Wenstrom KD, Sipes SL, et al. Risk factors for cordocentesis and fetal intravascular transfusion [J]. Am J Obstet Gynecol, 1991, 165(4 Pt 1): 1020-1025.
[27]
Jauniaux E, Donner C, Simon P, et al. Pathologic aspects of the umbilical cord after percutaneous umbilical blood sampling [J]. Obstet Gynecol, 1989, 73(2): 215-218.
[28]
Brambati B, Lanzani A, Tului L. Transabdominal and transcervical chorionic villus sampling: efficiency and risk evaluation of 2, 411 cases [J]. Am J Med Genet, 1990, 35(2): 160-164.
[29]
Philip J, Silver RK, Wilson RD, et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial [J]. Obstet Gynecol, 2004, 103(6): 1164-1173.
[30]
Borgida AF, Mills AA, Feldman DM, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis [J]. Am J Obstet Gynecol, 2000, 183(4): 937-939.
[31]
Devlieger R, Millar LK, Bryant-Greenwood G, et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence [J]. Am J Obstet Gynecol, 2006, 195(6): 1512-1520.
[32]
Ghi T, Sotiriadis A, Calda P, et al. ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis [J]. Ultrasound Obstet Gynecol, 2016, 48(2): 256-268.
[33]
Giorlandino C, Cignini P, Cini M, et al. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial [J]. Prenat Diagn, 2009, 29(6): 606-612.
[34]
Hobbins JC, Pilu G, Abuhumad A, et al. Antibiotic prophylaxis before amniocentesis [J]. Prenat Diagn, 2011, 31(12): 1213-1214.
[35]
Gramellini D, Fieni S, Casilla G, et al. Mid-trimesteramniocentesis and antibiotic prophylaxis [J]. Prenat Diagn, 2007, 27(10): 956-959.
[36]
Mujezinovic F, Alfirevic Z. Technique modifications for reducing the risks from amniocentesis or chorionic villus sampling [J]. Cochrane Database Syst Rev, 2012, 8: CD008678.
[37]
Boulot P, Deschamps F, Lefort G, et al. Pure fetal blood samples obtained by cordocentesis: Technical aspects of 322 cases [J]. Prenat Diagn, 1990, 10(2): 93-100.
[38]
Wladimiroff JW, Sachs ES, Reuss A, et al. Prenatal diagnosis of chromosome abnormalities in the presence of fetal structural defects [J]. Am J Med Genet, 1988, 29(2): 289-291.
[39]
Cao F, Xie X, Gollan T, et al. Comparison of gene-transfer efficiency in human embryonic stem cells [J]. Mol Imaging Biol, 2010, 12(1): 15-24.
[40]
Botto LD, Olney RS, Mastroiacovo P, et al. Chorionic villus sampling and transverse digital deficiencies: evidence for anatomic and gestational-age specificity of the digital deficiencies in two studies [J]. Am J Med Genet, 1996, 62(2): 173-178.
[41]
Firth H. Chorion villas sampling and limb deficiency-cause or coincidence? [J]. Prenat Diagn, 1997, 17(13): 1313-1330.
[42]
Cross HE, Maumenee AE. Ocular trauma during amniocentesis [J]. Arch Ophthalmol, 1973, 90(4): 303-304.
[43]
Epley SL, Hanson JW, Cruikshank DP. Fetal injury with midtrimester diagnostic amniocentesis [J]. Obstet Gynecol, 1979, 53(1): 77-80.
[44]
Cambiaghi S, Restano L, Cavalli R, et al. Skin dimpling as a consequence of amniocentesis [J]. J Am Acad Dermatol, 1998, 39(5 Pt 2): 888-890.
[45]
Sepúlveda W, Quiroz V, Fernández R. Trauma of the fetal vessels during amniocentesis [J]. Rev Chil Obstet Ginecol, 1984, 49(2): 99-103.
[46]
Squier M, Chamberlain P, Zaiwalla Z, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy [J]. Dev Med Child Neurol, 2000, 42(8): 554-560.
[47]
Okyay RE, Gode F, Saatli B, et al. Late-onset maternal mortality after amniocentesis [J]. Eur J Obstet Gynecol Reprod Biol, 2011, 158(2): 367-368.
[1] 曾敬, 吴冬冬, 邵明, 范震波, 王治国, 刘培谊, 兰海峰. 高龄髋部骨折患者不同手术时机的围手术期疗效评估[J]. 中华关节外科杂志(电子版), 2024, 18(04): 445-449.
[2] 赵飞鸿, 陈颖杰, 林静芳, 郑晓春, 廖燕凌. 超声引导下周围神经阻滞对髋膝关节置换术后恢复的影响[J]. 中华关节外科杂志(电子版), 2024, 18(04): 457-468.
[3] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[4] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[5] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[8] 向辉, 贾晓斌, 全卫涛. 真空辅助乳腺微创旋切术治疗乳腺纤维瘤的效果及并发症观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 528-530.
[9] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[10] 李澄清, 郭文毅, 王磊. 腹腔镜保留脾脏胰体尾切除术:微创胰腺外科的合理决策[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 620-624.
[11] 罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[12] 韩青雷, 丛赟, 李佳隆, 邵英梅. 术前减黄方式对壶腹周围癌胰十二指肠切除术后并发症的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 665-669.
[13] 冀旭, 朱峰, 冯业晨. 保留器官功能的胰腺切除术后胆道并发症发生危险因素分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 509-514.
[14] 陈先志, 许磊, 冯其柱, 王琦. 布地奈德联合复方异丙托溴铵雾化吸入在老年患者腹腔镜围手术期中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 531-536.
[15] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
阅读次数
全文


摘要